These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23628798)

  • 1. Differential effects of insulin-like growth factor-1 CA repeat polymorphism on breast cancer risk along with race: a meta-analysis.
    He B; Xu Y; Pan Y; Li R; Gao T; Song G; Gu L; Nie Z; Chen L; Wang S
    Gene; 2013 Aug; 525(1):92-8. PubMed ID: 23628798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
    Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
    Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1 CA repeat variant and breast cancer risk in postmenopausal women.
    González-Zuloeta Ladd AM; Liu F; Houben MP; Arias Vásquez A; Siemes C; Janssens AC; Coebergh JW; Hofman A; Janssen JA; Stricker BH; van Duijn CM
    Eur J Cancer; 2007 Jul; 43(11):1718-22. PubMed ID: 17561390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
    Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
    Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women.
    Wen W; Gao YT; Shu XO; Yu H; Cai Q; Smith JR; Zheng W
    Int J Cancer; 2005 Jan; 113(2):307-11. PubMed ID: 15386404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
    Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
    Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
    Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
    Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
    Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
    Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
    Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
    Qiu LX; Yuan H; Yu KD; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
    Breast Cancer Res Treat; 2010 Jun; 121(3):703-8. PubMed ID: 19936916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
    Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
    Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.
    Missmer SA; Haiman CA; Hunter DJ; Willett WC; Colditz GA; Speizer FE; Pollak MN; Hankinson SE
    Int J Cancer; 2002 Jul; 100(3):332-6. PubMed ID: 12115549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States.
    Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T
    Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
    Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J
    Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women.
    Figer A; Karasik YP; Baruch RG; Chetrit A; Papa MZ; Sade RB; Rizel S; Friedman E
    Isr Med Assoc J; 2002 Oct; 4(10):759-62. PubMed ID: 12389335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.
    Tran N; Bharaj BS; Diamandis EP; Smith M; Li BD; Yu H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2133-40. PubMed ID: 15598771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Di-nucleotide repeat polymorphisms of the insulin-like growth factor-1 gene and their association with IGF-1, insulin-like growth factor-binding protein-1 and birth size in a Sri-Lankan cohort.
    Jayanthiny P; Tennekoon KH; Karunanayake EH; Kumarasiri JM; Wijesundera AP
    Neonatology; 2011; 100(1):37-43. PubMed ID: 21196777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.